Location:Home > Company > Press Release > 2013

World’s largest newborn hearing-loss related genetic screen



CapitalBio, in association with six leading Beijing hospitals, recently undertook the world’s largest screen of babies born in Beijing Municipal Region in 2012 for 10 mutations in 5 genesassociated with congenital hearing defects using the CapitalBio Deafness Gene Mutation Detection Microarray Kit. Blood spot samples from over 240,000 newborns were analysed, indentifying more than 11,000 mutant alleles.  All positive mutations were confirmed by independent DNA sequencing.  This early screening facilitates medical intervention with genetically deaf children, while identifying and genotyping numerous at risk children prior to conventional auditory testing. Significantly, the survey found more than 610 babies with lesions in mitochondrial genes that confer sensitivity to aminoglycoside antibiotics which can cause irreparable deafness after limited exposure. The early identification of this genetic sensitivity will be used to avoid exposure of the child to these drugs throughout their lifetime. Importantly, other members of the maternal side of the child’s family will also carry the lesions, and the newborn screen could lead to numerous other affected persons to be identified and their hearing also preserved by strict avoidance of aminoglycoside antibiotics.
CapitalBio provided analysis instruments (BioMixer, SlideWasher, LuxScan 10KA), the CapitalBio Deafness Gene Mutation Detection Microarray Kits and developed dedicated informatics for the project.
四川血战麻将大胡有哪些 四川体育彩票七星彩 北京11选5任五号码推荐 篮网三加时胜骑士 南昌麻将百度版 熊猫成都麻将作弊器 黄金城棋牌下载 福彩快乐10分玩法 福彩36选7选码技巧 香港一波中特最准彩屯 nba灰熊vs网队比赛录像 陕西闲来麻将ios系统 二十一点赢钱概率 体育彩票网站 管家婆免费仓库管理软件 宁夏11选五电子版走势图 财神捕鱼辅助